✦ LIBER ✦

LB003-MON ORAL NUTRACEUTICAL FORMULA (PLP10) FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS: DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL

✍ Scribed by I.S. Patrikios; M.C. Pantzaris; G.N. Loukaides; E.E. Ntzani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioneer oral nutraceutical formula (PLP1

✍ Patrikios, I.S.; Loukaides, G.N.; Ntzani, E.E.; Pantzaris, M.C. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 211 KB

FP36-WE-02 Clinical outcomes of short-co

✍ G. Giovannoni; G. Comi; S. Cook; K. Rammohan; P. Rieckmann; P. Soelberg-Sørensen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PO10-TU-39 Safety and tolerability of sh

✍ S. Cook; P. Vermersch; G. Comi; G. Giovannoni; K. Rammohan; P. Rieckmann; P. Soe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

FP36-WE-03 MRI outcomes of short-course

✍ G. Comi; S. Cook; G. Giovannoni; K. Rammohan; P. Rieckmann; P. Soelberg-Sørensen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB